April 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreApril 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
According to market projections, the oligonucleotide synthesis sector is expected to grow from USD 5.59 billion in 2024 to USD 20.31 billion by 2034, reflecting a CAGR of 13.78%. The growing demand for the biotechnology industry drives the market’s growth....
April 21, 2026
Projections indicate that, multiplex assay industry is projected to rise from USD 1.72 billion in 2024 to USD 6.75 billion by 2034, reflecting a CAGR of 14.79% over the next decade. North America is expected to maintain its leading position by 38.50% revenue share while the Asia Pacific region is anticipated to see substantial growth during the for...
April 21, 2026
Market insights predict, the gRNA industry is expected to grow from USD 592.66 million in 2024 to USD 3,296.45 million by 2034, driven by a CAGR of 18.72%. Growing research in genomics due to rare diseases and gene and cell therapy drives the use of gRNA....
April 21, 2026
Projections indicate that, the global biological safety testing market will increase from USD 5.43 billion in 2024 to USD 15.07 billion by 2034, experiencing a CAGR of 10.75% over the next 10 years. The Growing concern regarding the safety of products in the pharma and biotech industry drives the growth of the market....
April 21, 2026
Projections indicate that, the global aseptic sampling market will increase from USD 1.02 billion in 2024 to USD 2.31 billion by 2034, experiencing a CAGR of 7.76% over the next 10 years. The growing prevalence of chronic conditions demand for pharmaceuticals and biotechnology products, which increases the usage of aseptic sampling procedures....
April 21, 2026
Based on market forecasts, the automated cell counting sector will expand from USD 4.48 billion in 2024 to USD 14.51 billion by 2034, experiencing a CAGR of 12.48%. Cell counting is needed in cell culture applications, monitoring of cell culture, development of cell-based assays, and many other processes associated with cell counting, which promote...
April 21, 2026
According to market estimations, the pharmaceutical water market is projected to grow at a robust CAGR of 9.25% from 2024 to 2034. North America led with a 35% market share in 2023, while Asia Pacific is anticipated to expand at the fastest rate of 10.34% during the forecast period. In 2023, water for injection dominated the market with a 79% share...
April 21, 2026
Based on market forecasts, the global perfusion systems market, projected at USD 1.21 billion in 2024, is expected to reach USD 1.94 billion by 2034, growing at a CAGR of 4.85% over the forecast period. The increasing incidence of cardiovascular, respiratory, and renal disorders and awareness of organ donation drive the perfusion systems market....
April 21, 2026
Projections indicate that, recombinant lysyl endopeptidase industry is projected to rise from USD 40.01 million in 2024 to USD 67.06 million by 2034, reflecting a CAGR of 5.3% over the next decade. The rising demand for proteomics and genetic engineering, increasing investments, and rising chronic illnesses drive the market....
April 21, 2026
According to market projections, the nonspecific endonuclease market size to capture US$ 424.58 mn in 2025 and is to soar US$ 641.37 mn by 2030. The nonspecific endonuclease market is growing, driven by demand in gene therapy and genetic engineering, especially in North America and Asia Pacific. Used for DNA/RNA cleavage in research and therapy, th...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
